1. Introduction
===============

Optic atrophy (OPA) is a very tricky disorder, which involves the death of the retinal ganglion cell axons caused by various eye diseases, and results in optic nerve lesions.^\[[@R1],[@R2],[@R3]\]^ It often manifests as the degeneration and disappearance of optic nerve fibers, conduction dysfunction, visual field changes, vision decrease and loss.^\[[@R4],[@R5],[@R6]\]^ In China, previous study has reported that OPA ranks as the second factor in children\'s visual impairment, which seriously threatens quality of life in patients with this disorder.[@R7] Unfortunately, there are still no effective managements for treating this condition because of the complicated causes, and its poor prognosis.

Acupuncture has been utilized in clinical practice in China for thousands of years.^\[[@R8],[@R9],[@R10],[@R11]\]^ It has been used to treat a variety of conditions and has achieved a promising effectiveness.^\[[@R12],[@R13],[@R14],[@R15],[@R16],[@R17],[@R18],[@R19],[@R20]\]^ Several previous studies have reported that acupuncture may also benefit for patients with OPA.^\[[@R21],[@R22],[@R23],[@R24],[@R25],[@R26]\]^ However, its effectiveness for this disorder is still inconclusive. Thus, this study will comprehensively and systematically assess the effectiveness and safety of acupuncture for patients with OPA.

2. Methods and analysis
=======================

2.1. Study registration
-----------------------

This study has been registered on PROSPERO (CRD42019135785), and we have reported it in accordance with the guidelines of the Preferred Reporting Items for Systematic Reviews and Meta-analysis Protocol.

2.2. Eligibility criteria for study selection
---------------------------------------------

### 2.2.1. Types of studies

Any randomized controlled trials (RCTs) and case-controlled trials (CCTs) of acupuncture for the treatment OPA will be considered for inclusion. However, nonclinical trials, and noncontrol trials will be excluded.

### 2.2.2. Types of patients

We will include any diagnosed criteria of OPA regardless their race, sex, and age.

### 2.2.3. Types of interventions

We will include studies that have implemented acupuncture monotherapy as an experimental treatment.

Control therapy can be any treatments, except any forms of acupuncture therapies.

### 2.2.4. Types of outcomes

Eligible studies will be included if more than one of the following outcomes have reported.

#### 2.2.4.1. Primary outcome

1.  Rate of vision improvement;

2.  Rate of visual field improvement.

#### 2.2.4.2. Secondary outcome

1.  Increased visual field average sensitivity;

2.  Pattern visual evoked potential (PVEP) amplitude;

3.  Shortened PVEP latency;

4.  Any expected and unexpected adverse reactions.

2.3. Search strategy for study identification
---------------------------------------------

### 2.3.1. Electronic databases searches

This study will include a comprehensive literature search from PUMBED, EMBASE, CINAHI, Cumulative Index to Nursing and Allied Health Literature, Allied and Complementary Medicine Database, Cochrane Library, Chinese Biomedical Literature Database, and China National Knowledge Infrastructure, and other literature sources from their inceptions to the present regardless any language restrictions. The search strategy for PubMed is detailed in Table [1](#T1){ref-type="table"}. Identical search strategies will also be used for any other electronic databases.

###### 

Search strategy for PubMed.

![](medi-98-e16879-g001)

### 2.3.2. Other literature sources

We will also retrieve any other gray literature sources, such as conference proceedings, dissertations, and reference lists of eligible studies.

2.4. Study selection
--------------------

Two independent authors will check the titles and summaries for each retrieved record according to the eligibility criteria. After that, all irrelevant records will be excluded. Then, the remaining records will be read by full-texts and will be judged if they meet the finally eligibility criteria. Any disagreements regarding the study selection between 2 authors will be solved by a third author through discussion. The flowchart of all study selection procedure is shown in Figure [1](#F1){ref-type="fig"}.
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2.5. Data extraction and management
-----------------------------------

Two trained authors will independently extract the required information from all eligible studies according to the pre-designed data extraction form. A third trained author will help to check and to solve any disagreements occurred between 2 authors. Extracted information consists of publication details, general characteristics of eligible studies (such as name, title, publication year, and so on), patient details (such as sex, age, and so on), details of treatments, as well as the outcome measurements.

2.6. Missing data dealing with
------------------------------

Where applicable, any missing data will be inquired by contacting primary authors by using email. When it is not possible, only available data will be analyzed. Meanwhile, we will discuss its possible effects on the combined outcome results.

2.7. Risk of bias assessment
----------------------------

In this study, we will apply different assessment tools to evaluate different types of studies. We will use Cochrane risk of bias tool to assess the risk of bias for all RCTs, and the risk of bias for all CCTs will be evaluated by using newcastle--ottawa scale. Two trained authors will independently assess the risk of bias for each eligible study. If there are disagreements between 2 authors, a third trained author will be asked for help to solve those disagreements by discussion.

2.8. Rating quality of evidence
-------------------------------

In this study, the overall strength of the evidence will also be assessed by Grading of Recommendations Assessment, Development, and Evaluation tool.[@R27] We will summarize the results in the tables of Summary of Findings.

2.9. Statistical analysis
-------------------------

RevMan 5.3 software will be utilized for statistical analysis in this study.

### 2.9.1. Treatment effects measurements

Continuous data will be expressed as mean difference or standardized mean difference with 95% confidence intervals.

Dichotomous data will be employed by using as risk ratio with 95% confidence intervals.

### 2.9.2. Assessment of heterogeneity

We will assess heterogeneity by using *I* ^2^ test. If *I* ^2^ ≤50%, minor heterogeneity will be regarded. Otherwise, if *I* ^2^ \> 50%, substantial heterogeneity will be observed in this study. Then, subgroup analysis will be conducted to identify any possible reasons that can result in substantial heterogeneity.

### 2.9.3. Data synthesis

If minor heterogeneity is found (*I* ^2^ ≤50%), a fixed-effects model will be employed for data pooling, and meta-analysis will be carried out. If significant heterogeneity is found (*I* ^2^ \> 50%), a random-effects model will be employed for data pooling. At the same time, subgroup analysis will also be conducted. If there is still substantial heterogeneity after subgroup analysis, data will not be pooled, and meta-analysis will not be carried out. Instead, we will report narrative summary for outcome results.

### 2.9.4. Subgroup analysis

Subgroup analysis will be applied in accordance with different characteristics, treatment types, and outcome tools.

### 2.9.5. Sensitivity analysis

Sensitivity analysis will be conducted to identify the robustness and stability of pooled outcome results by removing low quality of studies.

### 2.9.6. Reporting bias analysis

If \>10 qualified studies are included, Funnel plot and Egger regression analysis will be carried out to check the publication bias.

3. Discussion
=============

OPA is a very common and tricky disorder, and can result in vision decrease or even loss, which significantly affect their quality of life. Several previous studies have reported that acupuncture can treat OPA effectively and safety.^\[[@R12],[@R13],[@R14],[@R15],[@R16],[@R17],[@R18],[@R19],[@R20]\]^ However, its effectiveness for treating this disorder is still inconclusive. Therefore, this study will systematically assess the effectiveness and safety of acupuncture for the treatment of patients with OPA. The findings of this study will summarize most recent evidence of acupuncture for treating OPA.
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